Form 4 for ADMA ADMA BIOLOGICS, INC.
Accepted 2025-02-03 00:00:00 ET · period of report 2025-01-30 · accession 0001140361-25-002926 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-03 | 2025-01-30 | ADMA | Kestenberg-Messina Kaitlin M. | COO, SVP, Compliance | F - Tax | $16.10 | -3,355 | 446.2K | -0.7% | -$54.0K |
| D | 2025-02-03 | 2025-01-30 | ADMA | Kestenberg-Messina Kaitlin M. | COO, SVP, Compliance | M - OptEx | $10.80 | +5,000 | 449.6K | +1% | +$54.0K |
| D | 2025-02-03 | 2025-01-30 | ADMA | Kestenberg-Messina Kaitlin M. | COO, SVP, Compliance | M - OptEx | $0.00 | -5,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-30 | F | D | 3,355 | $16.10 | 446,232 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements and payment by the Reporting Person of the option exercise price. This is not an open market sale of securities. This option was automatically exercised on the expiration date. (F3) (continued from footnote 2) (iv) 20,000 unvested RSUs granted on March 7, 2022, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (v) 5,000 unvested RSUs granted on February 25, 2021, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; and (vi) 135,162 shares of common stock owned by the reporting person, which reflects the option exercise described in footnote 1 and prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes. (F2) Includes, as of the transaction date (i) 192,320 unvested RSUs granted on April 1, 2024, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 22,500 unvested RSUs granted on July 24, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (iii) 71,250 unvested RSUs granted on March 6, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; |
| 2 | Common | Common Stock | 2025-01-30 | M | A | 5,000 | $10.80 | 449,587 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2025-01-30 | M | D | 5,000 | $0.00 | 0 | D | $10.80 · — to 2025-01-30 | 5,000 Common Stock | (F4) The option was granted on January 30, 2015 and is fully vested. |